Bryn Mawr Capital Management Inc’s Zimmer Biomet ZBH Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-30,964	Closed	-$2.82M	–	305
2015 Q3	$2.82M	Sell	30,964 -8,946	-22%	-$897K	0.49%	70
2015 Q2	$4.23M	Buy	+39,910	New	+$4.42M	0.62%	45
2013 Q4	–	Sell	-37,482	Closed	-$2.99M	–	665
2013 Q3	$2.99M	Buy	+37,482	New	+$2.95M	0.19%	150

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bryn Mawr Capital Management Inc's ZBH Position: Q4 2015 in Review

Bryn Mawr Capital Management Inc sold out of Zimmer Biomet (ZBH) in Q4 2015, closing a stake of 30,964 shares — an estimated $2.82M sold.

Bryn Mawr Capital Management Inc first reported a position in ZBH in Q3 2013 and held it in 3 quarters. The position peaked at $4.23M in Q2 2015. 739 funds tracked by Wall St. Rank hold ZBH as of Q4 2015.

Bryn Mawr Capital Management Inc reported no remaining Zimmer Biomet position as of Q4 2015 after selling out during the quarter.
Bryn Mawr Capital Management Inc sold 30,964 Zimmer Biomet shares in Q4 2015, an estimated $2.82M.
Bryn Mawr Capital Management Inc first reported a position in Zimmer Biomet in Q3 2013 and held it in 3 quarters.
Bryn Mawr Capital Management Inc's Zimmer Biomet position peaked at $4.23M in Q2 2015.
739 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q4 2015.